Unisphere Establishment Takes Position in Danaher Corporation $DHR

Key Points

• Unisphere Establishment acquired 33,000 shares of Danaher Corporation, valued at approximately $6,765,000, as reported in a recent 13F filing with the SEC.
• Various hedge funds have increased their stakes in Danaher, with 79.05% of the company's stock currently held by institutional investors.
• Danaher reported quarterly earnings with an EPS of $1.80, exceeding analysts' expectations, and set its FY 2025 guidance at 7.700-7.800 EPS.

Unisphere Establishment purchased a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 33,000 shares of the conglomerate's stock, valued at approximately $6,765,000.

Other large investors have also recently made changes to their positions in the company. MGO One Seven LLC raised its stake in shares of Danaher by 485.7% during the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock worth $5,145,000 after acquiring an additional 20,813 shares in the last quarter. Asahi Life Asset Management CO. LTD. purchased a new position in shares of Danaher during the first quarter worth approximately $539,000. Horizon Financial Services LLC raised its stake in shares of Danaher by 20,400.0% during the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock worth $1,681,000 after acquiring an additional 8,160 shares in the last quarter. Texas Capital Bank Wealth Management Services Inc raised its stake in shares of Danaher by 6.1% during the first quarter. Texas Capital Bank Wealth Management Services Inc now owns 34,763 shares of the conglomerate's stock worth $7,126,000 after acquiring an additional 2,009 shares in the last quarter. Finally, EFG Asset Management Americas Corp. raised its stake in shares of Danaher by 13.1% during the first quarter. EFG Asset Management Americas Corp. now owns 36,080 shares of the conglomerate's stock worth $7,396,000 after acquiring an additional 4,191 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Trading Up 0.6%

Danaher stock traded up $1.29 during mid-day trading on Friday, reaching $200.32. 2,837,584 shares of the company traded hands, compared to its average volume of 2,859,442. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The firm's 50 day moving average price is $201.93 and its 200 day moving average price is $199.41. The firm has a market capitalization of $143.44 billion, a price-to-earnings ratio of 42.62, a P/E/G ratio of 2.78 and a beta of 0.75. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company's quarterly revenue was up 3.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

DHR has been the topic of several analyst reports. Barclays reaffirmed an "overweight" rating and issued a $225.00 target price (up from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Evercore ISI decreased their target price on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research note on Tuesday, July 8th. Guggenheim reaffirmed a "buy" rating and issued a $250.00 target price on shares of Danaher in a research note on Wednesday, July 23rd. Scotiabank raised shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price on the stock in a research note on Friday, July 11th. Finally, UBS Group decreased their target price on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a research note on Wednesday, July 23rd. Seventeen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $246.35.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the business's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 11.10% of the company's stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.